Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025 and Jan 2026.
- Largest single sale: $1.3M (48,057 shares) of Enliven Therapeutics, Inc. on Jan 9, 2026. Filing
- Last sale before this period: Oct 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Chief Operating Officer | Feb 27, 2023 | Feb 17, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 12, 2026, Enliven Therapeutics, Inc.: 20,000 shares granted. 1 filing: 1
- Jan 9, 2026, Enliven Therapeutics, Inc.: sold 48,300 shares for $1.4M, under a disclosed plan (some held indirectly). 1 filing: 1
- Dec 8, 2025, Enliven Therapeutics, Inc.: sold 6,663 shares for $140K, under a disclosed plan (some held indirectly). 1 filing: 1
- Nov 7, 2025, Enliven Therapeutics, Inc.: sold 6,667 shares for $116K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.